Bioorganic and Medicinal Chemistry Letters p. 157 - 160 (1999)
Update date:2022-08-05
Topics:
Matulic-Adamic, Jasenka
Daniher, Andrew T.
Gonzalez, Carolyn
Beigelman, Leonid
Previously developed '5-ribo' nuclease stabilized hammerhead motif was further refined by systematic incorporation of 1-(β-D-xylofuranosyl) adenine (xA) and 1-(β-D-xylofuranosyl) guanine (xG) in the place of conserved ribopurine residues of the catalytic core. Modified ribozymes substituted with xA at positions A15.1 and A6 demonstrated catalytic activity close to the parent stabilized ribozyme. Analogous guanosine substitutions at positions G5, G8 and G12 substantially lowered catalytic rates.
View MoreLuoyang Aoda chemical Co.,Ltd.
Contact:+86-379-67518785 67516588
Address:MiaoWan industry district,YanShi City,Henan,China
AUSHUN PHARMACEUTICAL TECHNOLOGY CO,.LTD
Contact:+86-25-86883560 15951806178
Address:14 Dayingbi, Zhujiang Rd. East, Nanjing, Jiangsu, China.
WUXI KINGHAN BIO-MEDICAL&CHEMICAL INC.
Contact:13861062998
Address:Room 1316,No.1619 Huishan Avenue,Wuxi,China
Changzhou LanXu Chemical Co.,ltd.(expird)
Contact:86-0519-86330911,13656129734,15261186386
Address:Room 524, Depart.Chemical, Changzhou Science and Eductaion town, Jiangsu, China;Factory: Haian Fine Chemical Industry Park,Nantong,Jiangsu,China
Jiangxi Dongbang Pharmaceutical Co., Ltd.
Contact:+86-795-4433603, 4433388
Address:Fengxin Industrial Park, Fengxin County, Jiangxi Province, P.R.C
Doi:10.1021/om9900061
(1999)Doi:10.1515/znb-1999-0210
(1999)Doi:10.1021/ja01030a025
(1969)Doi:10.1016/S0022-2860(01)00471-9
(2001)Doi:10.1021/om980691w
(1999)Doi:10.1016/S0040-4039(99)00187-2
(1999)